Write in a clean editor, then format for JACC Asia in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JACC Asia is a peer-reviewed journal published by Elsevier, covering Cardiac Valve Diseases and Treatments, Atrial Fibrillation Management and Outcomes, Coronary Interventions and Diagnostics.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, JACC Asia 12 (2023) 45–58.
Formats any DOI in JACC Asia style. No sign-up. |
| Publishes research in | Cardiac Valve Diseases and Treatments Atrial Fibrillation Management and Outcomes Coronary Interventions and Diagnostics Cardiovascular Function and Risk Factors Cardiac Imaging and Diagnostics |
| ISSN | 2772-3747 |
| Citation impact (2-yr) | 2.03 |
| h-index | 29 |
| i10-index | 154 |
| Total citations | 5,225 |
| Article processing charge | $2,500 |
| Open access | Yes |
| Top institutions publishing here | Chinese Academy of Medical Sciences & Peking Union Medical College |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Cardiovascular disease (CVD) is the leading cause of death in Asia. To combat the harmful impacts of CVD on public health in Asian countries with more effective strategies and actions, it is crucial to understand the current epidemiologic features of CVD in Asia. Through a systematic study and analysis of various timely data on CVD…
Elevated concentration of lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease, including coronary artery disease, stroke, peripheral artery disease, and so on. Emerging data suggest that Lp(a) contributes to the increased risk for cardiovascular events even in the setting of effective reduction of plasma low-density lipoprotein cholesterol. Nevertheless, puzzling issues exist covering…
Heart failure (HF) represents a complex clinical syndrome affecting multiple organs and systems of the body, which is a global public health concern because of its high prevalence, mortality, and medical cost. Asia, with its vast population, diverse ethnicities, and complex health care systems, faces challenges in the prevention and management of HF. However, unlike…
Cardiovascular disease (CVD) has increasing challenges for human health with an increasingly aging population worldwide, imposing a significant obstacle to the goal of healthy aging. Rapid advancements in our understanding of biological aging process have shed new light on some important insights to aging-related diseases. Although numerous reviews delved into the mechanisms through which biological…
The epidemiology and management of valvular heart disease (VHD) have changed with economic development and population aging in China in recent decades. This study sought to understand the distribution, etiology, and presentation and assess the current practice and outcomes of older patients with VHD in China. The authors conducted the first nationwide survey of older…
